Tom Wilkinson

Tom Wilkinson

University of Southampton

H-index: 57

Europe-United Kingdom

About Tom Wilkinson

Tom Wilkinson, With an exceptional h-index of 57 and a recent h-index of 45 (since 2020), a distinguished researcher at University of Southampton, specializes in the field of Respiratory Medicine, Immunology, Digital Health.

His recent articles reflect a diverse array of research interests and contributions to the field:

Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

Characterising user engagement with mHealth for chronic disease self-management and impact on machine learning performance

Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations

Structural Predictors of Lung Function Decline in the British Early COPD Network (BEACON) Cohort

Characterization of Factors Associated With Disease Severity in Adults Hospitalized With Respiratory Viral Infection: The Universal Study

Clinical Development of Inhaled Interferon Beta-1a (SNG001) for the Treatment of Patients With COVID-19 in the Home and Hospital Settings

Nebulised interferon-Β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study

Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroid

Tom Wilkinson Information

University

Position

___

Citations(all)

15335

Citations(since 2020)

7254

Cited By

10304

hIndex(all)

57

hIndex(since 2020)

45

i10Index(all)

118

i10Index(since 2020)

116

Email

University Profile Page

University of Southampton

Google Scholar

View Google Scholar Profile

Tom Wilkinson Skills & Research Interests

Respiratory Medicine

Immunology

Digital Health

Top articles of Tom Wilkinson

Title

Journal

Author(s)

Publication Date

Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

The Journal of Allergy and Clinical Immunology: In Practice

Bo Ding

Stephanie Chen

Eleni Rapsomaniki

Anna Quinton

William Cook

...

2024/4/1

Characterising user engagement with mHealth for chronic disease self-management and impact on machine learning performance

npj Digital Medicine

Christopher Duckworth

Bethany Cliffe

Brian Pickering

Ben Ainsworth

Alison Blythin

...

2024/3/12

Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations

Peter Kardos

Jaime Correia de Sousa

Ulrich Heininger

Andreas Konstantopoulos

C Raina MacIntyre

...

2024/12/31

Structural Predictors of Lung Function Decline in the British Early COPD Network (BEACON) Cohort

American journal of respiratory and critical care medicine

Andrew I Ritchie

Gavin C Donaldson

Eric A Hoffman

James P Allinson

Chloe I Bloom

...

2024/1/4

Characterization of Factors Associated With Disease Severity in Adults Hospitalized With Respiratory Viral Infection: The Universal Study

TG Morelli

M Purcell

O Cox

P Lee

K Thorne

...

2024/5

Clinical Development of Inhaled Interferon Beta-1a (SNG001) for the Treatment of Patients With COVID-19 in the Home and Hospital Settings

PD Monk

J Brookes

V Tear

T Batten

M Mankowski

...

2023/5

Nebulised interferon-Β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study

ERJ open research

Phillip D Monk

Jody L Brookes

Victoria J Tear

Toby N Batten

Marcin Mankowski

...

2023/3/1

Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroid

2023/8/3

Collagen Remodelling in COPD: A new paradigm

Alex Chia Wei Kong

Tom Havelock

Cosma Mirella Spalluto

Ashley Heinson

Graham Belfield

...

2023/9/9

375. The Effect of Inhaled Interferon Beta-1a (SNG001) Treatment Compared to Placebo on Lung Antiviral Biomarkers and Viral Clearance in Chronic Obstructive Pulmonary Disease …

Open Forum Infectious Diseases

Phillip D Monk

Jody L Brookes

Victoria J Tear

Toby Batten

Clare Newall

...

2023/12

Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial

Frontiers in Pharmacology

Merlin L Willcox

Xiao-Yang Hu

Tom Oliver

Kerensa Thorne

Cherish Boxall

...

2023/9/25

Change in COPD Assessment Test (CAT) score from a stable baseline has a high predictive capability for acute exacerbations

Henry Glyde

Alison M Blythin

Tom M Wilkinson

Ian T Nabney

James W Dodd

2023/9/9

Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD

ERJ Open Research

Ventzislava A Hristova

Alastair Watson

Raghothama Chaerkady

Matthew S Glover

Jodie Ackland

...

2023/5/1

Patient-centered discussions about disease progression, symptom, and treatment burden in chronic obstructive pulmonary disease could facilitate the integration of end-of-life …

Journal of Palliative Medicine

Nuno Tavares

Nikki Jarrett

Tom MA Wilkinson

Katherine J Hunt

2023/3/1

Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease

Cell host & microbe

Weijie Liang

Yuqiong Yang

Shenhai Gong

Mingyuan Wei

Yingfei Ma

...

2023/6/14

Characterisation of clinical risk factors for severity and outcome in adults hospitalised with respiratory viral infection (RVI): the UNIVERSAL study.

Tommaso Morelli

Martha Purcell

Pedro Rodrigues

Sandra Aitken

Charles Roberts

...

2023/9/9

S108 Biological predictors of severity in respiratory viral infection (RVI): preliminary data from UNIVERSAL, a multicentre prospective observational study

T Morelli

M Purcell

A Kong

B Welham

C Roberts

...

2023/11/1

Pulmonary surfactant in adult ARDS: Current perspectives and future directions

Ahilanandan Dushianthan

Michael PW Grocott

Ganapathy Senthil Murugan

Tom MA Wilkinson

Anthony D Postle

2023/9/15

Can tracheobronchial tree and luminal descriptors be used as objective imaging biomarkers in COPD?

Rodrigo Nava

François-Xavier Blé

Cosma Mirella Spalluto

Karl Staples

Tom Wilkinson

...

2023/9/9

The role of SARS-CoV-2 receptor ACE-2 isoforms in SARS-CoV-2 infection in the airway epithelium

CM Spalluto

MV Humbert

MTT Dalbay

G Ponzio

M Fierville

...

2023/3/9

See List of Professors in Tom Wilkinson University(University of Southampton)

Co-Authors

H-index: 126
Jadwiga Wedzicha

Jadwiga Wedzicha

Imperial College London

H-index: 98
Ratko Djukanovic

Ratko Djukanovic

University of Southampton

H-index: 82
Gavin Donaldson

Gavin Donaldson

Imperial College London

H-index: 68
J R Hurst

J R Hurst

University College London

H-index: 45
Professor Stuart C. Clarke

Professor Stuart C. Clarke

University of Southampton

H-index: 44
Stephen A Wootton

Stephen A Wootton

University of Southampton

academic-engine